Status:
COMPLETED
Efficacy Evaluation Of Great Occipital Nerve Electrical Stimulation On Rebound Headache
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
HEADACHE
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
SENGO-CAM study is a sham-controlled simple blind trial which aim is to study the efficacy of great occipital nerve stimulation (GONS) associated with medication withdrawal in the treatment of medicat...
Eligibility Criteria
Inclusion
- age \> 18 years old
- migraine patient with medication overuse headache by non specific analgesics according to the ICHD-II diagnostic criteria
- failure of outpatient withdrawal
- Signature of informed consent.
- Affiliation to French national health and pensions organization
Exclusion
- pregnancy (positive pregnancy test at pre-study) and breast-feeding
- patients with medication overuse headache by specific antimigraine treatment (triptans or/and ergot derivatives) according to the ICHD-II diagnostic criteria
- previous surgical treatment targeting great occipital nerves
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01184222
Start Date
November 1 2010
End Date
December 1 2012
Last Update
March 18 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurology department - La timone
Marseille, France
2
Neurosurvery department
Nice, France
3
Headache Emergency Center
Paris, France
4
Neurology department - CHU Rangueil
Toulouse, France